EPL Regulatory Approval

Results Update

EPL Results Update

EPL Limited's Q2 FY27 press release reports 30% revenue growth to ₹15,674 million and EBITDA up 17.6%. PAT rose 5.6% year-on-year, with high-teens guidance reaffirmed.

Earnings Call

EPL Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue ₹15,674mn (+30.0%), EBITDA ₹2,960mn (+17.6%, 18.9% margin), PAT ₹1,101mn (+5.6%). Personal Care & Beyond scaling; Indovida merger pending.

Financial Results

EPL Q2 FY27 Results: Net Profit ₹110.9 Cr, Up 4.5% YoY

EPL Ltd reported revenue from operations of ₹1,567 Cr (+30.0% YoY) and net profit of ₹110.9 Cr (+4.5% YoY) for Q2 FY27.

Key figure

Net profit ₹110.9 Cr · +4.5% YoY

Debt & Borrowing

EPL Debt & Borrowing

EPL certified CP proceeds for the quarter ended September 30, 2026 were used as disclosed. It is a periodic debt-listing compliance certificate, with no new money raised.

Board Meeting Date

EPL Board Meeting Date

EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.

Capital Structure Change

EPL Capital Structure Change

Bandhan Mutual Fund disclosed under SAST Regulation 29(2) that its holding in EPL rose to 9.3993% from 7.3596%. The fund bought 65,47,262 shares on the secondary market between September 28 and October 21, 2026.

Regulatory ApprovalSandur Manganese & Iron Ores Ltd SANDUMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sandur Manganese & Iron Ores Regulatory Approval

Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.

iron ore RoM capacity

9.42 MTPA

Regulatory ApprovalNeogen Chemicals Ltd NEOGENAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.